Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): a pragmatic randomised trial.
Beretta S, Beghi E, Messina P, Gerardi F, Pescini F, La Licata A, Specchio L, Ferrara M, Canevini MP, Turner K, La Briola F, Franceschetti S, Binelli S, Giglioli I, Galimberti CA, Fattore C, Zaccara G, Tramacere L, Sasanelli F, Pirovano M, Ferrarese C. Beretta S, et al. Among authors: fattore c. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):889-94. doi: 10.1136/jnnp-2013-306553. Epub 2014 Jan 8. J Neurol Neurosurg Psychiatry. 2014. PMID: 24403284 Clinical Trial.
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy.
Alexandre V Jr, Capovilla G, Fattore C, Franco V, Gambardella A, Guerrini R, La Briola F, Ladogana M, Rosati E, Specchio LM, Striano S, Perucca E; SOPHIE Study Group. Alexandre V Jr, et al. Among authors: fattore c. Epilepsia. 2010 May;51(5):921-5. doi: 10.1111/j.1528-1167.2009.02512.x. Epub 2010 Feb 3. Epilepsia. 2010. PMID: 20132292 Free article.
Novel medications for epilepsy.
Fattore C, Perucca E. Fattore C, et al. Drugs. 2011 Nov 12;71(16):2151-78. doi: 10.2165/11594640-000000000-00000. Drugs. 2011. PMID: 22035515 Review.
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.
Luoni C, Bisulli F, Canevini MP, De Sarro G, Fattore C, Galimberti CA, Gatti G, La Neve A, Muscas G, Specchio LM, Striano S, Perucca E; SOPHIE Study Group. Luoni C, et al. Among authors: fattore c. Epilepsia. 2011 Dec;52(12):2181-91. doi: 10.1111/j.1528-1167.2011.03325.x. Epilepsia. 2011. PMID: 22136077 Free article.
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial.
Franco V, Canevini MP, De Sarro G, Fattore C, Fedele G, Galimberti CA, Gatti G, La Neve A, Rosati E, Specchio LM, Striano S, Tinuper P, Perucca E; SOPHIE Study Group. Franco V, et al. Among authors: fattore c. Neurology. 2020 Jul 21;95(3):e239-e246. doi: 10.1212/WNL.0000000000009880. Epub 2020 Jun 29. Neurology. 2020. PMID: 32601123 Clinical Trial.
35 results